** Shares of Cambium Bio rise as much as 220% to A$0.016, its highest since early-July 2023
** Stock last up 140%, set for best day ever
** Clinical-stage regenerative medicine maker says it has successful completed the merger with Cambium Medical Technologies
** Adds, it will raise A$3.48 mln ($2.3 mln) in placement at A$0.006 per share, a 20% premium to its last close
** About 22.9 mln shares change hands, in its most active session on record
** Stock up ~67% YTD, as of last close
($1 = 1.5221 Australian dollars)
(Reporting by Neha Soni in Bengaluru)
((Neha.Soni@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.